Adial Pharmaceuticals Announces Closing of $9.2 Million Underwritten Public Offering and Exercise of Underwriters’ Over-Allotment Option

February 26, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search